Grant winners - 6 June 2013

六月 6, 2013

National Institute for Health Research

Health Services and Delivery Research Programme

Service provision for older people who are homeless and have memory problems

Public Health Research Programme

An overview of interventions aimed at improving outcomes for children exposed to domestic violence

Scoping the evidence on preventive interventions in domestic abuse for children and young people in the general population


Leverhulme Trust

Research Project Grants
Social sciences

Law and arms: the English medieval Court of Chivalry

Philip Leverhulme Prizes

  • Award winner: Ioannis Lianos
  • Institution: University College London
  • Value: £70,000

The interaction of economic thought with the legal system

Mathematics and statistics

Numerical analysis and applied analysis

Complex dynamics

Medieval, early modern and modern history

Modern history of race, empire and science


Arts and Humanities Research Council

Responsive Mode Grants

Musical impact: A study of the effects of music-making on musicians’ health and well-being

The cult of saints in Wales: medieval Welsh-language sources and their transmission


In detail

Efficacy and Mechanism Evaluation Programme

Award winner: Sven Plein
Institution: University of Leeds
Value: £589,199

Coronary artery disease evaluation in rheumatoid arthritis

Rheumatoid arthritis causes disabling joint changes, but also leads to other ailments (co-morbidities), of which heart disease is the most important and risky. The reason for this excess risk is thought to be widespread inflammation in the body. Newer treatments for rheumatoid arthritis effectively suppress inflammation in the joints, and it has been speculated that these treatments may also suppress the co-morbidities, particularly reducing the risk of heart disease. The team will use magnetic resonance imaging to detect early signs of heart disease in patients with a new diagnosis of rheumatoid arthritis and to test whether these changes are reversible with effective treatments of inflammation called biologics. If such effects can be shown, the management of rheumatoid arthritis could be changed to introduce biologics.



  • 注册是免费的,而且十分便捷
  • 注册成功后,您每月可免费阅读3篇文章
  • 订阅我们的邮件
Please 登录 or 注册 to read this article.